75 related articles for article (PubMed ID: 21839839)
1. Neuroblastoma genetics and phenotype: a tale of heterogeneity.
Speleman F; De Preter K; Vandesompele J
Semin Cancer Biol; 2011 Oct; 21(4):238-44. PubMed ID: 21839839
[TBL] [Abstract][Full Text] [Related]
2. [New insights into the genetic basis of neuroblastoma].
Speleman F; De Preter K; Hoebeeck J; Van Roy N; Vandesompele J
Verh K Acad Geneeskd Belg; 2007; 69(4):167-96. PubMed ID: 17821957
[TBL] [Abstract][Full Text] [Related]
3. Overall genomic pattern is a predictor of outcome in neuroblastoma.
Janoueix-Lerosey I; Schleiermacher G; Michels E; Mosseri V; Ribeiro A; Lequin D; Vermeulen J; Couturier J; Peuchmaur M; Valent A; Plantaz D; Rubie H; Valteau-Couanet D; Thomas C; Combaret V; Rousseau R; Eggert A; Michon J; Speleman F; Delattre O
J Clin Oncol; 2009 Mar; 27(7):1026-33. PubMed ID: 19171713
[TBL] [Abstract][Full Text] [Related]
4. Advances in the understanding of constitutional and somatic genomic alterations in neuroblastoma.
Deyell RJ; Attiyeh EF
Cancer Genet; 2011 Mar; 204(3):113-21. PubMed ID: 21504710
[TBL] [Abstract][Full Text] [Related]
5. Measurement and relevance of neuroblastoma DNA copy number changes in the post-genome era.
Mosse YP; Greshock J; Weber BL; Maris JM
Cancer Lett; 2005 Oct; 228(1-2):83-90. PubMed ID: 15967571
[TBL] [Abstract][Full Text] [Related]
6. Molecular pathogenesis of peripheral neuroblastic tumors.
Janoueix-Lerosey I; Schleiermacher G; Delattre O
Oncogene; 2010 Mar; 29(11):1566-79. PubMed ID: 20101209
[TBL] [Abstract][Full Text] [Related]
7. Integrative genomics identifies distinct molecular classes of neuroblastoma and shows that multiple genes are targeted by regional alterations in DNA copy number.
Wang Q; Diskin S; Rappaport E; Attiyeh E; Mosse Y; Shue D; Seiser E; Jagannathan J; Shusterman S; Bansal M; Khazi D; Winter C; Okawa E; Grant G; Cnaan A; Zhao H; Cheung NK; Gerald W; London W; Matthay KK; Brodeur GM; Maris JM
Cancer Res; 2006 Jun; 66(12):6050-62. PubMed ID: 16778177
[TBL] [Abstract][Full Text] [Related]
8. Neuroblastomas have distinct genomic DNA profiles that predict clinical phenotype and regional gene expression.
Mosse YP; Diskin SJ; Wasserman N; Rinaldi K; Attiyeh EF; Cole K; Jagannathan J; Bhambhani K; Winter C; Maris JM
Genes Chromosomes Cancer; 2007 Oct; 46(10):936-49. PubMed ID: 17647283
[TBL] [Abstract][Full Text] [Related]
9. Genetics and genomics of neuroblastoma.
Capasso M; Diskin SJ
Cancer Treat Res; 2010; 155():65-84. PubMed ID: 20517688
[TBL] [Abstract][Full Text] [Related]
10. Oligogenic inheritance in neuroblastoma.
Longo L; Tonini GP; Ceccherini I; Perri P
Cancer Lett; 2005 Oct; 228(1-2):65-9. PubMed ID: 15923081
[TBL] [Abstract][Full Text] [Related]
11. ArrayCGH-based classification of neuroblastoma into genomic subgroups.
Michels E; Vandesompele J; De Preter K; Hoebeeck J; Vermeulen J; Schramm A; Molenaar JJ; Menten B; Marques B; Stallings RL; Combaret V; Devalck C; De Paepe A; Versteeg R; Eggert A; Laureys G; Van Roy N; Speleman F
Genes Chromosomes Cancer; 2007 Dec; 46(12):1098-108. PubMed ID: 17823929
[TBL] [Abstract][Full Text] [Related]
12. Predicting outcomes for children with neuroblastoma.
Vermeulen J; De Preter K; Mestdagh P; Laureys G; Speleman F; Vandesompele J
Discov Med; 2010 Jul; 10(50):29-36. PubMed ID: 20670596
[TBL] [Abstract][Full Text] [Related]
13. [Prognosis of neuroblastoma in childhood. Methods of assessment and clinical use].
Pérel Y; Valteau-Couanet D; Michon J; Lavrand F; Coze C; Bergeron C; Notz A; Plantaz D; Chastagner P; Bernard F; Thomas C; Rubie H
Arch Pediatr; 2004 Jul; 11(7):834-42. PubMed ID: 15234382
[TBL] [Abstract][Full Text] [Related]
14. New technologies provide insights into genetic basis of psychiatric disorders and explain their co-morbidity.
Rudan I
Psychiatr Danub; 2010 Jun; 22(2):190-2. PubMed ID: 20562745
[TBL] [Abstract][Full Text] [Related]
15. High ALK receptor tyrosine kinase expression supersedes ALK mutation as a determining factor of an unfavorable phenotype in primary neuroblastoma.
Schulte JH; Bachmann HS; Brockmeyer B; Depreter K; Oberthür A; Ackermann S; Kahlert Y; Pajtler K; Theissen J; Westermann F; Vandesompele J; Speleman F; Berthold F; Eggert A; Brors B; Hero B; Schramm A; Fischer M
Clin Cancer Res; 2011 Aug; 17(15):5082-92. PubMed ID: 21632861
[TBL] [Abstract][Full Text] [Related]
16. Progress in treatment and risk stratification of neuroblastoma: impact on future clinical and basic research.
Øra I; Eggert A
Semin Cancer Biol; 2011 Oct; 21(4):217-28. PubMed ID: 21798350
[TBL] [Abstract][Full Text] [Related]
17. Increased WSB1 copy number correlates with its over-expression which associates with increased survival in neuroblastoma.
Chen QR; Bilke S; Wei JS; Greer BT; Steinberg SM; Westermann F; Schwab M; Khan J
Genes Chromosomes Cancer; 2006 Sep; 45(9):856-62. PubMed ID: 16804916
[TBL] [Abstract][Full Text] [Related]
18. [Utilization of MLPA to detection of genetic changes in neuroblastoma].
Vícha A; Eckschlager T
Klin Onkol; 2008; 21(4):149-53. PubMed ID: 19102220
[TBL] [Abstract][Full Text] [Related]
19. Molecular characterization and classification of neuroblastoma.
Oberthuer A; Theissen J; Westermann F; Hero B; Fischer M
Future Oncol; 2009 Jun; 5(5):625-39. PubMed ID: 19519203
[TBL] [Abstract][Full Text] [Related]
20. Genetic predisposition to familial neuroblastoma: identification of two novel genomic regions at 2p and 12p.
Longo L; Panza E; Schena F; Seri M; Devoto M; Romeo G; Bini C; Pappalardo G; Tonini GP; Perri P
Hum Hered; 2007; 63(3-4):205-11. PubMed ID: 17317969
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
